Proactiveinvestors recommends
Additional Information
Market: AIM
Sector: Healthcare, Equipment & Services
EPIC: AMEI
1 year chart More charts
digital-look imported chart image
Deal AMEI Tax Free*
*subject to change and depends on individual circumstances.
1 day chart More charts
digital-look imported chart image
Advertisement
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
African Medical Investments
www.africanmedicalinvestments.com
Deal African Medical Investments Tax Free* Losses can exceed
your initial deposit *subject to change and depends on individual circumstances.

African Medical Investments plc ('AMI') is an AIM listed company (AIM:AMEI) focussed on becoming a leading supplier of private specialist hospitals across Africa offering quality in and outpatient services. Its hospitals fill a crucial role for international standard healthcare demand from the burgeoning middle classes, overseas...

Read more
Full African Medical Investments profile here
Pdf

African Medical tops up finances with US$450,000 loan

March 07 2012, 8:57am The group runs private hospitals in Zimbabwe, Tanzania and Mozambique.

 

African Medical Investments (LON:AMEI) has raised a US$450,000 loan from Harbinger Capital, one of its main shareholders.

The group, which runs private hospitals in Zimbabwe, Tanzania and Mozambique, said the money will be used for additional working capital.

The unsecured loan notes carry a 10% per annum coupon (compounded annually) which is repayable with the principal by February 2016 at the latest.

African Medical is targeting the market for private healthcare as demand increases from the growing African middle classes and the expatriate, non-governmental organisations, diplomatic and tourist markets.

The company owns and operates private hospitals in Dar es Salaam, Maputo and Harare.

Losses in the six months to August reduced from US$11.9 million to US$3.9 million, which reflected a 58% reduction in head office expenses.

In August, African Medical raised US$700,000 from Harbinger, also through the issue of loan notes with a 10 per cent coupon.

Shares were up slightly today at 2.6p.

 

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.